BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer

SIMPLE SUMMARY: A combination of pertuzumab, trastuzumab, and chemotherapy is a standard treatment for patients with a type of breast cancer called HER2-positive. Before the BERENICE study, little was known about the safety and effectiveness of pertuzumab with trastuzumab after surgery. Cardiac safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Chau, Ewer, Michael S., Delaloge, Suzette, Ferrero, Jean-Marc, Colomer, Ramon, de la Cruz-Merino, Luis, Werner, Theresa L., Dadswell, Katherine, Verrill, Mark, Eiger, Daniel, Sarkar, Sriparna, de Haas, Sanne Lysbet, Restuccia, Eleonora, Swain, Sandra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179451/
https://www.ncbi.nlm.nih.gov/pubmed/35681574
http://dx.doi.org/10.3390/cancers14112596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179451/
https://www.ncbi.nlm.nih.gov/pubmed/35681574
http://dx.doi.org/10.3390/cancers14112596

Ejemplares similares